Santosh Kottayil
Direttore/Membro del Consiglio presso ACASTI PHARMA INC.
Patrimonio netto: 1 M $ in data 30/04/2024
Posizioni attive di Santosh Kottayil
Società | Posizione | Inizio | Fine |
---|---|---|---|
ACASTI PHARMA INC. | Direttore/Membro del Consiglio | 10/10/2023 | - |
Storia della carriera di Santosh Kottayil
Precedenti posizioni note di Santosh Kottayil
Società | Posizione | Inizio | Fine |
---|---|---|---|
ACASTI PHARMA INC. | Corporate Officer/Principal | - | 08/05/2023 |
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Part of Acasti Pharma, Inc., Grace Therapeutics LLC is a company that designs and develops drug delivery technology and products. The company is based in East Brunswick, NJ. The company was founded in 2014 by Vimal Kumar Kavuru, Santosh George Kottayil. Grace Therapeutics was acquired by Acasti Pharma, Inc. on August 27, 2021 for $63.41 million. | Amministratore Delegato | - | 01/08/2021 |
Fondatore | - | 01/08/2021 | |
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | Direttore Tecnico/Scientifico/R&S | 18/10/2002 | - |
Fondatore | 18/10/2002 | - | |
Presidente | 18/10/2002 | - |
Formazione di Santosh Kottayil
University of Kentucky | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
President | 1 |
Settori
Health Technology | 3 |
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ACASTI PHARMA INC. | Health Technology |
Aziende private | 2 |
---|---|
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | Health Technology |
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Part of Acasti Pharma, Inc., Grace Therapeutics LLC is a company that designs and develops drug delivery technology and products. The company is based in East Brunswick, NJ. The company was founded in 2014 by Vimal Kumar Kavuru, Santosh George Kottayil. Grace Therapeutics was acquired by Acasti Pharma, Inc. on August 27, 2021 for $63.41 million. | Commercial Services |
- Borsa valori
- Insiders
- Santosh Kottayil
- Esperienza